Congress Secretariat:

E.T.S. Events & Travel Solutions S.A.154 El. Venizelou Str N. Smyrni, Athens, Greece, 171 22Tel.: +30 210 98 80 032, Fax.: +30 210 98 81 303Ε-mail: ets@events.gr, ets@otenet.gr Website: www.events.gr

28 - 31 January 2015 Athens - GreeceEUGENIDES FOUNDATION

SA

VE T

HE D

ATE

endorsed by

Medical Oncology& Hematology Board Review Course

This program has the American Society of Clinical Oncology’s approval for quality of educational content. ASCO endorsement does not constitute medical advice. Health care providers should exercise their own independent medical judgment.

ASCO® is a registered trademark of the American Society of Clinical Oncology®. Used with permission. This is not an ASCO sponsored event.

Hematology• Understand the diagnosis,

work-up, and managementof hematologic malignancies;

• Understand the most recentadvances in the pharmacolo-gy and side-effects of anti-neoplastic drugs

Oncology• Understand the epidemiology

of malignant diseases and treat- ment of the medical complica-tions of malignancy;

• Recognize the recent advancesand the principles of manage-ment of solid tumors

• Recognize principles of new de-velopments in molecular the ra-py of cancer.SA

VE T

HE D

ATE

endorsed by

28 -

31 J

anua

ry 2

015

Athe

ns -

Gre

ece

EU

GEN

IDES F

OU

ND

ATIO

N

FacultyGhassan Abou-Alfa (Memorian Sloan Kettering

Cancer Center,USA)Jafer Ajani (MD Anderson, USA)Jean Yves Blay (University Claude Bernard Lyon, FR)Barbara Burtness (Yale Cancer Center, USA)Johann Sebastian DeBono (The Institute of Cancer Research, UK)Andreas Engert (University Hospital of Cologne, DE)Edward P. Gelmann (Herbert Irving Comprehensive

Cancer Center Columbia University, USA)Steven Lipkin (Weill Cornell Medical College, USA)Kjell Öberg (University Hospital, Uppsala, SE)Eileen O'Reilly (Memorian Sloan Kettering

Cancer Center, USA)Solange Peters (Département d'Oncologie - CHUV, CH)David Rimm (Yale University School of Medicine, USA)Fausto Roila (S. Maria Hospital, IT)Tanguy Seiwert (University of Chicago, USA)Jan B. Vermorken (Antwerp University Hospital, BE)

Join your colleagues in medical oncology and hematology for this com-prehensive review of clinical best practices presented by the interna-tional experts in the field. This ASCO-endorsed medical oncology and hematology Course is de-signed to prepare hematology and oncology fellows planning to certi-fy or recertify in medical oncology and / or hematology Board exami-nations. It is the first international board review course. Depending on the exam you are preparing to take you can register forthe 2-day Hematology, 3-day Oncology or the 4-day combined course.

Learning Objectives:

Medical Oncology& Hematology Board Review Course